Tines introduces the ability to build apps with its no-code automation platform 26-01-2023, 21:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Fashion Brand LOVALL Improves Fulfilment Productivity with Descartes’ Ecommerce Warehouse Management System 2-04-2024, 17:45